| Financial Year |
March 31 2023 |
| Monetary Funds |
631,915,123.22 |
| Held-for-trading Financial Assets |
60,751,978.99 |
| Notes Receivable |
22,577,479.08 |
| Accounts Receivable |
203,703,351.14 |
| Advances to Suppliers |
6,583,670.55 |
| Other Receivables |
5,101,177.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,688,668.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,583,169.21 |
| Total Current Assets |
1,106,401,947.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,096,054.49 |
| Investment Properties |
-- |
| Fixed Assetes |
313,502,378.73 |
| Under-construction Projects |
44,358,741.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,707,212.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,552,421.20 |
| Deferred Income Tax Assets |
4,424,418.65 |
| Other Non-Current Assets |
17,878,757.02 |
| Sub-Total of Non-Current Assets |
510,572,999.82 |
| Total Assets |
1,616,974,947.62 |
| Short-Term Loans |
160,899,978.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
58,225,274.40 |
| Accounts Payable |
91,708,107.54 |
| Accounts Received In Advance |
19,756.56 |
| Employee Compensation Payable |
13,809,039.54 |
| Taxes Payable |
12,285,940.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,888,231.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,809,763.17 |
| Other Current Liabilities |
26,212.51 |
| Sub-Total of Current Liabilities |
355,873,939.11 |
| Long-term Loans |
1,437,486.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
850,970.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,738,090.50 |
| Total Liabilities |
369,612,029.61 |
| Paid-In Capital(Or Share Stock) |
235,883,907.00 |
| Capital Surplus |
488,718,518.36 |
| Surplus Reserve |
55,022,170.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
477,915,466.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,247,362,918.01 |
| Owner's Equity（Stockholder's Equity） |
1,247,362,918.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,616,974,947.62 |
